Unlocking Market Potential From Natural Tocotrienols (T3)

Unlocking Market Potential From Natural Tocotrienols (T3)

Invictus BioPharma Ltd. is an Australian public unlisted biotechnology company developing and commercialising novel nutraceuticals and prescription medicines based on natural products (tocotrienols) which have wide therapeutic potential, including: Delayed Onset Muscle Soreness (DOMS), muscle recovery after exercise, maintenance of peak muscle power, exercise endurance, Non-Alcoholic Fatty Liver Disease (NAFLD), pancreatic cancer, hyperlipidaemia and diabetes. 

Invictus BioPharma owns and controls patent and other intellectual property rights for novel approaches to delivering tocotrienols directly to the target tissues. The Company has a product development program for evidence-based nutraceuticals and a clinical development program for prescription medicines.

TOP